泸溪哪里算卦比较准-【火明耀】,推荐,百色算命哪个准,九江算命灵验的地方是哪里,南皮哪个地方算命准,阜新哪里算命比较准,丰镇哪里算卦算的好,克拉玛依算命看事哪家准

The Dow Jones Industrial Average continued its volatile run on Monday, closing down 200 points. At one point during the day, the index was about 350 points above its previous close.Struggling tech stocks and fears about trade tariffs have led to selling sprees in the past month. The market is down about 2,000 points from where it opened in October.More on this as it develops. 391
The cost of education can last a lifetime, as many people into their 50s and 60s are finding out.According to Federal Reserve, 2.8 million people in the U.S. over the age of 60 are sitting on some amount of student debt, a number that quadrupled from 700,000 in 2005 and continues to grow.“This is really a sledgehammer against the older generation in more ways than one,” says Alan Collinge, creator of online advocacy group for borrowers Student Loan Justice.Collinge has been campaigning for change surrounding laws for student loans since 2005, after trying to figure out a way to pay off his own crippling college costs.“It’s a really devastating phenomenon, and I’m seeing it destroy, literally wreck, families across the country,” Collinge says. In 2018, Americans over the age of 50 owed more than 0 billion in student loans, up from billion in 2004, according to the Federal Reserve.And most can’t afford to pay, forcing retirees to continue to work well past retirement age.“The problem has become exponentially worse since we began this fight 13 years ago,” he says.In Collinge’s group, he hears stories from people ages 18 to 80 years old, who can hardly afford to live, let alone retire.“The federal government can and does garnish Social Security from seniors as a result of their student loans, so we’re hearing stories from people who at the end of the month they’re unable to buy medicine even unable to pay their rent,” Collinge says, “What kind of country does this to their senior people?”On top of that, Collinge says more people in their 50s and 60s are taking out Parent Plus loans to help their children and grandchildren pay for college, which adds to the financial burden.“This is a nationally threatening phenomenon,” he said. Through his advocacy group, he tries to offer help and resources to folks who are struggling. He’s currently on a road tour talking to legislators around the country, encouraging them to reform borrower laws, expand their rights and get colleges to crack down on sky-high tuition costs.“Student loans are the only loans in the country not subject to bankruptcy, why is that? The numbers are just getting so astonishing now, I can only hope that the new Congress puts this issue front and center and doesn’t get distracted by the palace intrigue because this is a problem affecting real people it just won’t wait any longer.” 2413

The founder of Tower Records died Sunday while drinking whiskey and watching the Oscars, the Sacramento Bee reported.Russ Solomon ran the music store chain until it went bankrupt in 2006.At its height, Tower Records operated in 20 countries. The Tokyo branch was once the world’s largest music store.Solomon’s son believes his father died of a heart attack, according to the Sacramento Bee.Solomon was 92 years old.RELATED: Oscars get lowest ratings in show's historyThe Associated Press contributed to this report. 528
The destructive storm surge has receded, and the clean up has begun from Hurricane Laura in Texas and Louisiana. But officials along this shattered stretch of Louisiana coast are warning returning residents they will face weeks without power or water amid the hot, stifling days of late summer. Hundreds of thousands of people in two of the hardest-hit states are reported to be without power following the severe storm.The U.S. toll from the Category 4 hurricane stood at 16 deaths, with more than half of those killed by carbon monoxide poisoning from the unsafe operation of generators. President Donald Trump landed in Louisiana Saturday afternoon to tour the damage in Louisiana and will head to Texas next. 720
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee has endorsed Pfizer’s coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak. The group, in a 17-4 vote with one abstention, concluded that the shot appears safe and effective against the coronavirus in people 16 and older.The Food and Drug Administration is expected to follow the recommendation issued Thursday by its expert advisers. A final FDA decision is expected within days. The vaccine had already been authorization by officials in Canada and the UK.An emergency use authorization allows practitioners to administer a vaccine despite it not gaining full FDA approval. The EUA means that the vaccine is allowed to be used in non-clinical settings, which would allow Americans not in a trial or hospital setting to get the vaccine.Millions of shots would then ship to begin vaccinating health care workers and nursing home residents, but the Centers for Disease Control and Prevention will need to formally recommend the vaccine before health care officials can begin distributing the shots.Once it is authorized, it is expected that several million doses of the vaccine will immediately begin being distributed throughout the US to high-risk individuals. The first group of those expected to be inoculated includes health care workers and those who live or work in assisted living facilities.“The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want to assure the American people that the FDA’s process and evaluation of the data for a potential COVID-19 vaccine will be as open and transparent as possible,” said FDA Commissioner Stephen M. Hahn, M.D. “The FDA has been preparing for the review of EUAs for COVID-19 vaccines for several months and stands ready to do so as soon as a EUA request is submitted. While we cannot predict how long the FDA’s review will take, the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner, so that we can help make available a vaccine that the American people deserve as soon as possible.”Pfizer says that the vaccine is showing a 95% efficacy against coronavirus infection. It is one of two vaccines that could be approved by the FDA in the next few weeks. Moderna also has a vaccine candidate that is showing the efficacy of 95%.“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally. Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” said Dr. Albert Bourla, Pfizer Chairman and CEO. “We look forward to the upcoming Vaccines and Related Biological Products Advisory Committee discussion and continue to work closely with the FDA and regulatory authorities worldwide to secure authorization of our vaccine candidate as quickly as possible.”One concern over the Pfizer vaccine is possible side effects on those prone to allergic reactions. The UK’s National Health Service is advising those prone to allergic reactions to not take the Pfizer vaccine as it investigates two health care workers having apparent reactions after receiving the vaccine.Once given authorization, officials will be forced to confront two challenges: Public confidence in the vaccine and distribution. Both the Moderna and Pfizer vaccines are required to be refrigerated until use, complicating distribution methods.Also, polls are showing that a significant number of Americans are hesitant to take the vaccine. Public health experts say getting the vast majority of Americans immunized is important in order to reach herd immunity against the virus and to allow for normalcy to return to the US.In addition to a number of public health experts saying they’ll get the vaccine as a way to instill trust, former Presidents Bill Clinton, George W. Bush, and Barack Obama said they would publicly take the vaccine in order to instill faith in the shot.Widespread access to the general public is not expected until the spring. 4342
来源:资阳报